The value of FDG PET/CT in treatment response assessment, follow-up, and surveillance of lung cancer

Sara Sheikhbahaei; Esther Mena; Anusha Yanamadala; Siddaling Reddy; Lilja B. Solnes; Jason Wachsmann; Rathan M. Subramaniam

doi:10.2214/AJR.16.16532

The value of FDG PET/CT in treatment response assessment, follow-up, and surveillance of lung cancer

Sara Sheikhbahaei, Esther Mena, Anusha Yanamadala, Siddaling Reddy, Lilja B. Solnes, Jason Wachsmann, Rathan M. Subramaniam

Research output: Contribution to journal › Review article › peer-review

80 Scopus citations

Abstract

OBJECTIVE. The purpose of this article is to summarize the evidence regarding the role of FDG PET/CT in treatment response assessment and surveillance of lung cancer and to provide suggested best practices. CONCLUSION. FDG PET/CT is a valuable imaging tool for assessing treatment response for patients with lung cancer, though evidence for its comparative effectiveness with chest CT is still evolving. FDG PET/CT is most useful when there is clinical suspicion or other evidence for disease recurrence or metastases. The sequencing, cost analysis, and comparative effectiveness of FDG PET/CT and conventional imaging modalities in the follow-up setting need to be investigated.

Original language	English (US)
Pages (from-to)	420-433
Number of pages	14
Journal	American Journal of Roentgenology
Volume	208
Issue number	2
DOIs	https://doi.org/10.2214/AJR.16.16532
State	Published - Feb 2017

Keywords

FDG PET/CT
Follow-up
Lung cancer
Recurrence detection
Therapy assessment

ASJC Scopus subject areas

Radiology Nuclear Medicine and imaging

Access to Document

10.2214/AJR.16.16532

Cite this

@article{97cdc89c82094a7b9b3f8d3e7713cc4a,

title = "The value of FDG PET/CT in treatment response assessment, follow-up, and surveillance of lung cancer",

abstract = "OBJECTIVE. The purpose of this article is to summarize the evidence regarding the role of FDG PET/CT in treatment response assessment and surveillance of lung cancer and to provide suggested best practices. CONCLUSION. FDG PET/CT is a valuable imaging tool for assessing treatment response for patients with lung cancer, though evidence for its comparative effectiveness with chest CT is still evolving. FDG PET/CT is most useful when there is clinical suspicion or other evidence for disease recurrence or metastases. The sequencing, cost analysis, and comparative effectiveness of FDG PET/CT and conventional imaging modalities in the follow-up setting need to be investigated.",

keywords = "FDG PET/CT, Follow-up, Lung cancer, Recurrence detection, Therapy assessment",

author = "Sara Sheikhbahaei and Esther Mena and Anusha Yanamadala and Siddaling Reddy and Solnes, {Lilja B.} and Jason Wachsmann and Subramaniam, {Rathan M.}",

year = "2017",

month = feb,

doi = "10.2214/AJR.16.16532",

language = "English (US)",

volume = "208",

pages = "420--433",

journal = "American Journal of Roentgenology",

issn = "0361-803X",

publisher = "American Roentgen Ray Society",

number = "2",

}

TY - JOUR

T1 - The value of FDG PET/CT in treatment response assessment, follow-up, and surveillance of lung cancer

AU - Sheikhbahaei, Sara

AU - Mena, Esther

AU - Yanamadala, Anusha

AU - Reddy, Siddaling

AU - Solnes, Lilja B.

AU - Wachsmann, Jason

AU - Subramaniam, Rathan M.

PY - 2017/2

Y1 - 2017/2

N2 - OBJECTIVE. The purpose of this article is to summarize the evidence regarding the role of FDG PET/CT in treatment response assessment and surveillance of lung cancer and to provide suggested best practices. CONCLUSION. FDG PET/CT is a valuable imaging tool for assessing treatment response for patients with lung cancer, though evidence for its comparative effectiveness with chest CT is still evolving. FDG PET/CT is most useful when there is clinical suspicion or other evidence for disease recurrence or metastases. The sequencing, cost analysis, and comparative effectiveness of FDG PET/CT and conventional imaging modalities in the follow-up setting need to be investigated.

AB - OBJECTIVE. The purpose of this article is to summarize the evidence regarding the role of FDG PET/CT in treatment response assessment and surveillance of lung cancer and to provide suggested best practices. CONCLUSION. FDG PET/CT is a valuable imaging tool for assessing treatment response for patients with lung cancer, though evidence for its comparative effectiveness with chest CT is still evolving. FDG PET/CT is most useful when there is clinical suspicion or other evidence for disease recurrence or metastases. The sequencing, cost analysis, and comparative effectiveness of FDG PET/CT and conventional imaging modalities in the follow-up setting need to be investigated.

KW - FDG PET/CT

KW - Follow-up

KW - Lung cancer

KW - Recurrence detection

KW - Therapy assessment

UR - http://www.scopus.com/inward/record.url?scp=85010951259&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85010951259&partnerID=8YFLogxK

U2 - 10.2214/AJR.16.16532

DO - 10.2214/AJR.16.16532

M3 - Review article

C2 - 27726427

AN - SCOPUS:85010951259

SN - 0361-803X

VL - 208

SP - 420

EP - 433

JO - American Journal of Roentgenology

JF - American Journal of Roentgenology

IS - 2

ER -

The value of FDG PET/CT in treatment response assessment, follow-up, and surveillance of lung cancer

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this